Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Nerve Repair and Regeneration Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Nerve Repair and Regeneration Devices estimated at US$7.9 Billion in the year 2022, is projected to reach a revised size of US$17.6 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030.
Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to record 10.3% CAGR and reach US$14.7 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Biomaterials segment is readjusted to a revised 12.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 13.6% CAGR
The Nerve Repair and Regeneration Devices market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.
Select Competitors (Total 61 Featured) -
- Abbott Laboratories, Inc.
- AxoGen, Inc.
- Boston Scientific Corporation
- Integra LifeSciences Corporation
- LivaNova, PLC
- Medtronic plc
- NeuroPace, Inc.
- Nevro Corporation.
- Orthomed S.A.S.
- Polyganics B.V.
- Stryker Corporation
- Synapse Biomedical Inc.
- Synovis Micro Companies Alliance, Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 510 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $7.9 Billion |
| Forecasted Market Value (USD) by 2030 | $17.6 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. GLOBAL MARKET OVERVIEW
- Impact of Covid-19 and a Looming Global Recession
- 2020 Marked as a Year of Disruption & Transformation
- World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
- Global Nerve Repair & Regeneration Market Buckles under COVID-19 Strain
- Covid-19 Patients in Prone Position Suffering Nerve Damage Bodes Well for Market Growth
- Nerve Repair and Regeneration Market Set for a Robust Growth
- Neurostimulation & Neuromodulation Devices Hold Commanding Slot in Nerve Repair & Regeneration Market
- Biomaterials to Exhibit Rapid Growth
- Nerve Repair and Regeneration Market by Application
- US and Europe Dominate the Market
- Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- High Incidence of Neurological Disorders: A Key Market Driver
- Annual Incidence of Adult-Onset Neurologic Disorders in the US
- Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
- Increasing Cases of Peripheral Nerve Injuries Drive the Nerve Repair and Regeneration Market
- Growing Number of Vehicular Accidents Drive the Peripheral Nerve injuries Repair Market
- Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders
- Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
- Global Alzheimer's Prevalence by Age Group
- Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
- Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
- Select Available Deep Brain Stimulation Devices Available in the Market
- Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
- Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
- Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
- Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
- Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
- Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
- Recent Developments in Spinal Cord Injury Treatment
- Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid Growth
- New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies
- Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
- Innovative Nerve Conduits from Stryker
- TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
- Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
- Nerve Grafts for Bridging Larger Nerve Gaps
- Role of Nerve Grafting in Treatment of Peripheral Nerve Injuries
- FDA-approved Nerve Tubes for Peripheral Nerve Repair
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/za39p7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
